Using herpes drugs to slow down Alzheimer's disease could become reality

Umeå University researchers, led by Hugo Lövheim at the Department of Community Medicine and Rehabilitation and the Unit of Geriatric Medicine, have launched a clinical study investigating the effect of herpes drugs on Alzheimer's disease. For four weeks, 36 people with Alzheimer's disease will be receiving treatment with Valaciklovir, a drug which specifically targets active herpes virus. Several investigations will be made before and after the treatment to measure the effects on fundamental Alzheimer's disease processes. Moreover, the participants will be examined with brain imaging, which together with a tracer substance accumulating in cells with active herpes virus infection could potentially detect herpes virus infection in brain cells in people with Alzheimer's disease.
"I'm very excited about this study. In earlier population-based studies, we have seen that herpes virus infection increases the risk of Alzheimer's disease. It is very interesting to see if we can influence the neurodegenerative processes of Alzheimer's disease by using a well-established treatment of herpes," says Hugo Lövheim, lead researcher of the study and physician at the Geriatric Centre at the University Hospital of Umeå.
The study, named VALZ-Pilot, has been approved by the Medical Products Agency Sweden and the Regional Ethical Review Board in Umeå. The recruitment of study participants will be initiated in December 2016.
for more information visit our product website:
for more information visit our product website:Buy Suhagra 50 mg Online 
Location: United States

Comments

Post a Comment

Popular posts from this blog

Runners' brains may be more connected, research shows

University of Arizona researchers compared brain scans of young adult cross country runners to young adults who don't engage in regular physical activity. The runners, overall, showed greater functional connectivity -- or connections between distinct brain regions -- within several areas of the brain, including the frontal cortex, which is important for cognitive functions such as planning, decision-making and the ability to switch attention between tasks. Although additional research is needed to determine whether these physical differences in brain connectivity result in differences in cognitive functioning, the current findings, published in the journal  Frontiers in Human Neuroscience , help lay the groundwork for researchers to better understand how exercise affects the brain, particularly in young adults. UA running expert David Raichlen, an associate professor of anthropology, co-designed the study with UA psychology professor Gene Alexander, who studies brain aging a...
Read more

Gene related to brain damage in pre-term infants identified

Premature labour is associated with inflammation in the mother or baby, often due to infection. This can cause damage to the brain that could lead to lifelong conditions such as cerebral palsy, autism or learning or behavioural difficulties in up to 30 per cent of pre-term babies. Published in  Nature Communications , a new study investigated the role of microglial cells, which control the immune response in the brain, in responding to this inflammation. Researchers found a gene, known as DLG4, in these cells that is thought to be involved in controlling the inflammatory process. DLG4 is found in different forms in all humans but previously was thought only to play a role in the function of the nervous system. This new finding suggests it is also involved in the process of brain damage in some pre-term babies and may open doors for research into more effective treatments of these diseases. The study, which was a collaboration between King's , Inserm and Paris Diderot Univ...
Read more

Using antidepressants during pregnancy may affect your child's mental health

The researchers, headed by Xiaoqin Liu, have applied register-based research to the study of 905,383 children born between 1998 and 2012 with the aim of exploring the possible adverse effects of the mother's use of antidepressants during her pregnancy. They found that out of the 905,383 children in total, 32,400 developed a psychiatric disorder later in life. Some of these children were born to mothers who were on antidepressants during their pregnancy, while other children had not been exposed to medication. "When we look at children born to mothers who discontinued and continued antidepressant treatment during pregnancy, we can see an increased risk of developing a psychiatric disorder if the mothers continued antidepressant treatment while pregnant," says Xiaoqin Liu, who is the lead author of the article, which has just been published in  BMJ-British Medical Journal . More specifically, the researchers divided the children into four groups depending on the m...
Read more